Tando receives South African Reserve Bank approval

Published 27-AUG-2018 11:52 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Tando Resources Ltd (ASX:TNO) has advised that the final pre-condition to the company’s acquisition of a 73.95% stake in the SPD Vanadium Project, being South African Reserve Bank approval, has been satisfied and the transaction is now unconditional.

Tando expects the completion of the acquisition will occur imminently.

This comes on the back of recent exploration success at the project which is located in the north-eastern region of South Africa.

Approximately 85% of the world’s vanadium is produced in China, Russia and South Africa.

Given the SPD Vanadium Project is located in one of these producing regions, Tando believes that it has the potential to be globally significant based on its tonnage and grade in concentrate as indicated below.

Of course, Tando is in the early stages of its development, so investors should seek professional financial advice if considering this stock for their portfolio.

Analytical results pending

Only a fortnight ago, Tando identified a major new cluster of vanadium pipes at SPD.

Also, Tando announced in early August that a magnetic survey had identified a new 400 metre by 400 metre target in the north-east of the project, triggering a 15% share price rally.

The past performance of this product is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance

Since then, Tando has mapped and sampled the target area, confirming the presence of a new cluster of vanadium pipes.

Analytical results from these samples are pending, but on-ground inspection indicated that the pipes were very similar to those already mapped and sampled.

As a result, Tando has included this cluster on the list of targets which will be drilled as part of its upcoming program.

Further, Tando believes that confirmation of the presence of this new cluster provides more strong evidence of the potential for a low cost direct shipping ore (DSO) operation at SPD.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free